Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults

被引:94
作者
Larsen, C. N.
Nielsen, S.
Kaestel, P.
Brockmann, E.
Bennedsen, M.
Christensen, H. R.
Eskesen, D. C.
Jacobsen, B. L.
Michaelsen, K. F.
机构
[1] Royal Vet & Agr Univ, Dept Human Nutr, Ctr Adv Food Studies, DK-1958 Frederiksberg C, Denmark
[2] Chr Hansen AS, Horsholm, Denmark
[3] Tech Univ Denmark, Bioctr DTU, Biochem & Nutr Grp, DK-2800 Lyngby, Denmark
关键词
dose-response study; probiotics; cholesterol; recovery from feces; constipation;
D O I
10.1038/sj.ejcn.1602450
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: This study was performed to investigate the dose-response effects of supplementation with Bifidobacterium animalis subsp lactis (BB-12) and Lactobacillus paracasei subsp paracasei (CRL-431) on blood lipids, recovery from feces and bowel habits. Changes of the fecal microflora was analyzed in the 10(10) CFU/day probiotic and placebo group. Design: The study was designed as a randomized, placebo-controlled, double-blinded, parallel dose-response study. Subjects: Healthy young adults (18 - 40 years) were recruited by advertising in local newspapers. Of the 75 persons enrolled, 71 ( 46 women, 25 men, mean age 25.6 years ( range 18 - 40 years)) completed the study. Intervention: The volunteers were randomly assigned into five groups receiving either placebo or a mixture of the two probiotics in the concentration of 10(8), 10(9), 10(10) or 10(11) CFU/day in 2 weeks run-in period, 3 weeks intervention and 2 weeks wash-out. Diary reporting bowel habits and well being (abdominal bloating, flatulence and headache) was kept for all 7 weeks and blood lipids, fecal recovery of BB-12 and CRL-431, as well as fecal microflora was tested before, immediately and 2 weeks after intervention. Results: The fecal recovery of BB-12 increased significantly (P < 0.001) with increasing dose. In the group receiving 10(11) CFU/day BB-12 was recovered from 13 out of 15 volunteers. CRL-431 was not recovered in any of the fecal samples. Supplementation with probiotics did not change the fecal bacterial composition. A significant linear increase in fecal consistency (looser stool) with increasing probiotic dose (P=0.018) was observed. No overall dose - response effect was found on the blood lipids. High doses of probiotics were well tolerated. Conclusion: A dose-related recovery of BB-12 from feces was observed. Sponsorship: The study was sponsored by Chr. Hansen A/S, Hoersholm, Denmark.
引用
收藏
页码:1284 / 1293
页数:10
相关论文
共 53 条
[31]  
Laake K. O., 1999, Microbial Ecology in Health and Disease, V11, P211, DOI 10.1080/08910609908540830
[32]   EFFECT OF A FERMENTED INFANT FORMULA CONTAINING VIABLE BIFIDOBACTERIA ON THE FECAL FLORA COMPOSITION AND PH OF HEALTHY FULL-TERM INFANTS [J].
LANGHENDRIES, JP ;
DETRY, J ;
VANHEES, J ;
LAMBORAY, JM ;
DARIMONT, J ;
MOZIN, MJ ;
SECRETIN, MC ;
SENTERRE, J .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1995, 21 (02) :177-181
[33]   A double-blind placebo-controlled study of the effects of Lactobacillus acidophilus on plasma lipids [J].
Lewis, SJ ;
Burmeister, S .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2005, 59 (06) :776-780
[34]   ANTIMICROBIAL SUSCEPTIBILITY OF BIFIDOBACTERIA [J].
LIM, KS ;
HUH, CS ;
BAEK, YJ .
JOURNAL OF DAIRY SCIENCE, 1993, 76 (08) :2168-2174
[35]   Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women:: a double-blind, randomized, controlled study [J].
Marteau, P ;
Cuillerier, E ;
Meance, S ;
Gerhardt, MF ;
Myara, A ;
Bouvier, M ;
Bouley, C ;
Tondu, F ;
Bommelaer, G ;
Grimaud, JC .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (03) :587-593
[36]  
MUNOA FJ, 1988, APPL ENVIRON MICROB, V54, P1715
[37]   Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut [J].
Pereira, DIA ;
Gibson, GR .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2002, 68 (09) :4689-4693
[38]   Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis [J].
Rosenfeldt, V ;
Benfeldt, E ;
Valerius, NH ;
Pærregaard, A ;
Michaelsen, KF .
JOURNAL OF PEDIATRICS, 2004, 145 (05) :612-616
[39]   Effect of probiotic Lactobacillus strains in children with atopic dermatitis [J].
Rosenfeldt, V ;
Benfeldt, E ;
Nielsen, SD ;
Michaelsen, KF ;
Jeppesen, DL ;
Valerius, NH ;
Paerregaard, A .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (02) :389-395
[40]  
Saavedra J., 1998, J PEDIAT GASTROENTER, V27, P483, DOI [10.1097/00005176-199810000-00102, DOI 10.1097/00005176-199810000-00102]